Study to Assess Platelet Dysfunction With Verify Now Assay
NCT01167218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79
Last updated 2019-02-06
Summary
The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).
Conditions
- Platelet Aggregation Defects
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Nina D'abreo, MD · Winthrop University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
More Related Trials
-
Towards Improved Diagnostics for Suspected Platelet Function Disorders
NCT05985668 ·Status: RECRUITING
-
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
NCT04323748 ·Status: RECRUITING ·Phase: PHASE1
-
Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation
NCT00621894 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
NCT03951623 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Function With Various Storage Techniques
NCT03338660 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Platelet Glycoproteins in Inherited Thrombocytopathy: Association With Aggregation Studies and Bleeding Severity
NCT03648190 ·Status: UNKNOWN
-
The PROLONG Trial - Rituximab Maintenance Therapy in ITP
NCT03010202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada
NCT03784898 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
NCT01440361 ·Status: WITHDRAWN ·Phase: PHASE2
-
Eltrombopag Phase III Study In Chinese Chronic ITP Patients
NCT01762761 ·Status: COMPLETED ·Phase: PHASE3
-
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
NCT06722586 ·Status: RECRUITING ·Phase: PHASE4
-
A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)
NCT01433978 ·Status: TERMINATED ·Phase: PHASE3
-
Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
NCT01963260 ·Status: COMPLETED ·Phase: PHASE1
-
Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
NCT00902018 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
NCT06531018 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347
NCT03275740 ·Status: TERMINATED ·Phase: PHASE1
-
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
NCT00102323 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Eltrombopag at Escalated Doses
NCT01880047 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)
NCT01129024 ·Status: TERMINATED ·Phase: PHASE2
-
Platelet Products Tested With the ThromboLUX® Platelet Quality Test
NCT02158416 ·Status: COMPLETED
-
PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
NCT04842760 ·Status: UNKNOWN
-
Clinical Performance Evaluation of T-TAS 01 PL Chip
NCT03621020 ·Status: COMPLETED
-
Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
NCT00372892 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag
NCT00888901 ·Status: COMPLETED ·Phase: PHASE4